Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results
Business Wire•21/10/2026•16:05 ET
0
Key Highlights
- ➤Vir to report third-quarter 2026 financial results on November 4
- ➤Conference call scheduled for 4:30 p.m. ET / 1:30 p.m. PT
- ➤Vir’s clinical portfolio includes chronic hepatitis delta and oncology programs
Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, November 4 to provide a corporate update and discuss its financial results for the third quarter ended September 30, 2026. The conference call may be accessed on the Events & Presentations page of the Vir Biotechnology website.
Get started
Create a free account to read the full story.